Caption Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Caption Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$114M	Buy	894,100 +474,100	+113%	+$59.2M	0.67%	20
2025 Q4	$51.2M	Buy	420,000 +116,600	+38%	+$13.4M	0.35%	60
2025 Q3	$30.4M	Buy	303,400 +289,900	+2,147%	+$26.1M	0.24%	86
2025 Q2	$1.12M	Sell	13,500 -111,500	-89%	-$8.9M	0.01%	903
2025 Q1	$10.1M	Buy	+125,000	New	+$11.2M	0.1%	205
2024 Q1	–	Sell	-442,500	Closed	-$39.5M	–	1716
2023 Q4	$39.5M	Buy	442,500 +416,000	+1,570%	+$30.9M	0.53%	28
2023 Q3	$1.94M	Sell	26,500 -300,000	-92%	-$24M	0.03%	586
2023 Q2	$27.2M	Buy	326,500 +266,500	+444%	+$22.3M	0.48%	35
2023 Q1	$4.57M	Sell	60,000 -400,000	-87%	-$33.2M	0.09%	251
2022 Q4	$38.2M	Sell	460,000 -540,000	-54%	-$43.7M	0.6%	28
2022 Q3	$79.3M	Buy	1,000,000 +404,900	+68%	+$34.1M	1.09%	7
2022 Q2	$44.4M	Buy	595,100 +155,600	+35%	+$11.7M	0.61%	20
2022 Q1	$39.5M	Buy	439,500 +264,500	+151%	+$24.4M	0.48%	28
2021 Q4	$19.6M	Sell	175,000 -135,000	-44%	-$16.3M	0.22%	101
2021 Q3	$38.1M	Buy	+310,000	New	+$39.9M	0.44%	33
2021 Q2	–	Sell	-570,600	Closed	-$77.4M	–	1614
2021 Q1	$77.4M	Buy	+570,600	New	+$85.4M	1.66%	4
2020 Q4	–	Sell	-100,000	Closed	-$11.1M	–	1287
2020 Q3	$11.1M	Buy	+100,000	New	+$11.2M	0.26%	89
2019 Q2	–	Sell	-50,000	Closed	-$4.53M	–	848
2019 Q1	$4.53M	Sell	50,000 -90,000	-64%	-$7.66M	0.25%	124
2018 Q4	$10M	Buy	+140,000	New	+$11.3M	0.8%	25
2018 Q3	–	Sell	-75,000	Closed	-$7.14M	–	661
2018 Q2	$7.14M	Buy	+75,000	New	+$6.89M	0.55%	45

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Caption Management's XBI Position: Q2 2025 in Review

Caption Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 97,473 shares — an estimated $7.78M sold.

Caption Management first reported a position in XBI in Q1 2020 and held it in 12 quarters. The position peaked at $15.1M in Q1 2022. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Caption Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Caption Management sold 97,473 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $7.78M.
Caption Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 12 quarters.
Caption Management's State Street SPDR S&P Biotech ETF position peaked at $15.1M in Q1 2022.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.